Navigation Links
Cosmetic Surgeon Dr. Richard Buckley Comments on New Scientific Paper about E-Cigarette Use and Its Potential Impact on Cosmetic Surgery Complications
Date:3/14/2017

An expert panel has concluded that, based on current research, cosmetic surgery patients should stop using e-cigarettes a month prior to having any kind of cosmetic surgery. The scientific consensus, published in the Plastic and Reconstructive Surgery scientific journal, aims to keep cosmetic, or plastic, surgery patients safe from complications. “I agree with the recommendation,” says cosmetic surgeon Dr. Richard Buckley, medical director at MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. “We don’t yet know if e-cigarette use is as dangerous as traditional cigarette smoking for patients undergoing surgery and other procedures. What the experts who convened on this paper did was they reviewed the available science and determined that four weeks is the most prudent course of action for our patients at this time.”

It is well known that cigarette smoking increases the risk of complications during and after cosmetic surgery. Traditional smokers who have surgery are more likely than nonsmokers to die or have a heart attack or stroke within 30 days of surgery. They have higher risks of pneumonia, scarring and problems with wound healing than nonsmokers. Nicotine, in particular, has been found in many scientific articles to compromise wound healing and down-regulate collagen synthesis. When patients stop smoking in the weeks leading up to their surgeries, these effects rapidly improve. In plastic surgery, specifically, skin flap complications are thought to be linked to reduced blood flow, or vasoconstriction, from nicotine.

“It’s in patients’ best interests to quit smoking before any surgical procedure,” Dr. Buckley says. “We get a thorough health and smoking history to come up with a recommendation for our patients who smoke cigarettes or use tobacco or nicotine in any form including patches, so they’re as safe as possible during and after their procedures. The results from cosmetic surgery are also better when patients stop in the weeks prior to and after procedures.”

But the effects of inhaling nicotine from vapor are not clear. “The researchers went with a recommendation they feel is reasonable and is similar to what is advised with traditional nicotine inhalation products,” Dr. Buckley says. “They cite one study in which researchers studied 102 general surgery patients and found that by stopping smoking three to four weeks before surgery, smokers reduced the risk of complications after surgery from 41 percent to 21 percent. Continued research failed to show a similar benefit when surgical patients stopped smoking on to three weeks before their procedures. So, four weeks seemed the safest course of action for now.”

E-cigarettes, or vaping, continues to gain in popularity, but little is known how engaging in the habit impacts a person’s health. While it has been suggested that e-cigarettes, which don’t contain tar, might be less hazardous to health than traditional cigarettes, big questions remain about the long-term effects of nicotine-containing e-cigs, as well as potentially toxic substances in e-cigarette vapor. E-cigarettes are banned everywhere smoking is banned in Canada. FDA regulations requires that e-cigarette manufacturers get their products approved as “new tobacco products.”

“The only thing that’s clear at this point is that we need more definitive research to better understand the effects of vaporized nicotine on cosmetic surgery patients. An example would be to address the question: ‘How does vaping impact the survival of skin and soft tissue flaps?’” Dr. Buckley says. “Not only does smoking cessation help cosmetic surgery patients remain healthy during and after their procedures, but it also improves aesthetic results from face lifts to breast augmentation and liposuction.”

About MilfordMD Cosmetic Dermatology Surgery & Laser Center:

The MilfordMD Cosmetic Dermatology Surgery & Laser Center offers state-of-the-art highly specialized procedures in laser and cosmetic surgery and aesthetic skin care. In addition to its AAAHC accredited surgical center and extensive laser surgery capabilities, MilfordMD offers physician designed skin care products for home use. Milford Pennsylvania’s MilfordMD Cosmetic Dermatology Surgery & Laser Center is sought out by patients from around the world for expertise and innovation in cosmetic treatments performed by Richard E. Buckley, M.D. and Marina Buckley, M.D.

MilfordMD Cosmetic Dermatology Surgery & Laser Center is located at 303 W. Harford Street, Milford, PA 18337. Tel: (800) 664-1528. For real patient video testimonials, visit our MilfordMD YouTube channel.

Read the full story at http://www.prweb.com/releases/2016-03-14/E-Cigs-Health-Impact/prweb14133618.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Art of Dentistry, Premier Cosmetic Dentistry Practice, Invite New Patients for Discreet Invisalign® in San Diego, CA
2. Cosmetic Town Expands and Updates its Photo Gallery to Feature Even More Plastic Surgery Procedures
3. Healthpointe Welcomes Board-Certified ENT Specialist and Cosmetic / Facial Plastic Surgeon to their Anaheim Clinic
4. Houston Cosmetic Dentists at Antoine Dental Center Now Offer Comprehensive Cosmetic Treatments
5. Dr. Edward Buckingham Named One of Austin’s Best Cosmetic Surgeons
6. Cosmetic Town Now Makes It Easier Than Ever To Find Information about Plastic Surgery Procedures
7. Cosmetic Surgeon Dr. Richard Buckley Reveals New Uses for Tried-and-True Fillers in 2017
8. Cosmetic Surgeon Dr. Richard Buckley Comments on Reported National Trend: More Men Opting to Address Double Chin with the Injectable Treatment Kybella
9. Feminine Rejuvenation: Cosmetic Surgeon Dr. Richard Buckley Comments on New Study Looking at Why Women Want It; Why Women Do it
10. Rush for Holiday Procedures Underlines the Increasing Social Acceptance of Plastic Surgery and Cosmetic Treatments, says Beverly Hills Physicians
11. Scottsdale Institute for Cosmetic Dermatology Now Recommends Capillus272 Pro™ for Hair Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Plano, Texas (PRWEB) , ... May 26, 2017 , ... ... Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita ... , “We are pleased to be the first in Arkansas to introduce the ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... ... Water damage to the flooring of several classrooms at The Fort Lee Elementary ... number of critical issues to address before students could return to classes. , First, ... no disruption to class schedules. Second, the project had to comply with New Jersey ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
Breaking Medicine Technology: